Comparing ultrasound-guided ablation and laparoscopic surgery for adrenal tumors
Official title: Resident Doctor, Master Degree Candidate
Run by Third Affiliated Hospital, Sun Yat-Sen University · NCT05991856 · Data updated 2026-11-12
This study is testing whether ultrasound-guided radiofrequency ablation is as safe and effective as laparoscopic surgery for treating adrenal tumors in patients with aldosterone-producing adenoma.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 45 (estimated) |
| Sponsor | Third Affiliated Hospital, Sun Yat-Sen University Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Status | Recruiting |
| Started | January 1, 2020 |
| Main results expected | October 1, 2024 |
| Study ends | December 1, 2030 |
| Registry record updated | August 15, 2023 |
| Trial ID | NCT05991856 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with confirmed unilateral aldosterone-producing adenoma.
✕Probably not a fit
Patients with bilateral adrenal diseases, multiple adrenal tumors, or other adrenal conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to analyze the efficacy and safety of ultrasound-guided radiofrequency ablation versus laparoscopic adrenalectomy for treating aldosterone-producing adenoma (APA). It will involve a retrospective collection of data from 30 patients who underwent radiofrequency ablation and 15 patients who had laparoscopic adrenalectomy, matched by age and sex. The study will follow these patients for three years to assess long-term outcomes. This research is significant as it is one of the first to compare these two treatment methods in a larger cohort.
Why it matters
Potential benefit: If successful, this study could provide insights into a less invasive treatment option for patients with aldosterone-producing adenoma.
How similar studies have gone: While there have been few studies on this topic, the approach of using ultrasound-guided radiofrequency ablation is relatively novel and has shown promising results in preliminary cases.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. APA was confirmed with unilateral lesions; 2. Benign tumor without adrenal metastasis and endovascular tumor embolus; 3. Receive ultrasound-guided adrenal RFA treatment or laparoscopic resection, and sign the informed consent for surgery; 4. Age ≥ 18; 5. Age ≥ 40 years old should meet the following criteria: blood potassium ≤3.5mmol/L; PAC≥20ng/dL; PRC≤5μIU/mL; A unilateral adrenal nodule of 10mm or more was completely normal on the opposite side. Exclusion Criteria: 1. Bilateral adrenal diseases; 2. Multiple adrenal tumors; 3. Other adrenal diseases, such as adrenal hyperplasia, Cushing's syndrome, pheochromocytoma, etc.; 4. Imaging suggests that the tumor may be difficult to reach; 5. Imaging showed potential malignant adrenal tumor; 6. Pregnant and/or planning a pregnancy; 7. Refusing to participate in follow-up visits.
Where it's running
-
The Third Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China Recruiting
Study contacts
- Study coordinator: Xubin Yang, Dr
- Email: yxbin@mail.sysu.edu.cn
- Phone: 13763336436
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Endoscopic ultrasound-guided radiofrequency ablation for pancreatic and left adrenal lesions
This will try EUS-guided radiofrequency ablation to control symptoms and hormone-related problems in adults with small pancreatic neuroendocrine tumors (including insulinomas) or certain left adrenal adenomas.
-
Radiofrequency ablation for severe leg vein disease in people 80 and older
This will try radiofrequency ablation in people aged 80 and older with severe chronic venous insufficiency to see if it safely closes the leaking saphenous veins and improves symptoms and quality of life.
-
Radiofrequency ablation for benign or indeterminate thyroid nodules and low‑risk papillary thyroid cancer
This project sees if radiofrequency ablation shrinks benign or indeterminate thyroid nodules and controls low‑risk papillary thyroid cancer in adults, and how the treatment affects patients' quality of life.
-
How radiofrequency ablation affects esophagus stretchiness and mucosal impedance
This study will test whether radiofrequency ablation changes how stretchy the esophagus is and the mucosal impedance in adults treated for dysplastic Barrett's esophagus.
-
Using Gallium-68 Pentixafor PET-CT to improve surgery outcomes in primary aldosteronism
This trial will test whether adding gallium-68 pentixafor PET/CT to standard adrenal venous sampling helps people with primary aldosteronism have better results from adrenal surgery.
-
Impact of breathing methods on heart procedure success for atrial fibrillation
This study tests whether using different breathing methods during a heart procedure for atrial fibrillation can help improve the success of the treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.